Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Accr4g02609 | ATGAACATGACAATCGCACCATGGAAGTATCATGTTTTCTTGAGCTTCAGAGGAGAAGACACCCGAAAAGGCTTCACAGACCACTTAAACGCTACTCTAAAACAAAGAGGTATCATAACTTTCTTAGATGATAAGCTCAATAAAGGAGAGGTTATTTCTGATCAACTCCTCTTAGCAATTGATGAATCTCTCATCTCTCTTGTTATTCTCTCTGAAAGTTATGCCTCTTCTAGATGGTGTTTGGATGAACTTCAAAGGATTCTTGAATCTAAAAAATCTTTGGGTAGAGAAGTTATCCCAATCTTCTATAAGGTTGATCCGTCTGATGTGCGTTATCAAAGAGGTACCTTTGGTTGCGCCCTTCAAAAACATGGTGACAGATTTGCTGAAAACAAAGACAAGGTGCAAAGATGGAAAGATGCCTTAAAAGAAGTTGCAAATATATCAGGCTATGACTCTAGGGACCGGAATGAAGGGAAACTCATTGAAGAAATTGTTGCAGACGTATGGTCAAAGCTACAACCTAAATTATCATATTGTTTCAGTAACGAGCTTGTTGGCATTGAATCAAAGATAGAGCAAGTGAATTCACTTTTAAAGATTGGATTGGATGATGGTCGTCGTCGCTTCCTAGGAATTTGGGGCATGGGTGGTATAGGTAAAACAACTCTTGCAAGAGAGATCTTTGAGAGAATATGTGGCGACTTTGACATGAGTTGTTTTCTCGCTAATGTTAAAGAAAAATCTGAAACCAAGCAGGGTTTGGTTTACTTGCAAAGAAGACTTCTTTCCAAACTCAAGATAAGAGACTTAGAAGTTGATGATACATATGAGGGAAGGAATCTAATAAGAAACTTGCTGTGCAACAAAAAACTTCTACTTGTGTTGGATAATGTAAGTGAAATAAGCCAACTAGAAAACCTTTCAATAAAACAAGCCTGGTTGGGTTGTGGCAGTCGAGTAATAGTGACAACTAGGAATCTCCAAGTATTGATAGCACATGGAGAATTTGAAATATATGAGGCTGAATTATTAAATGATAATGAGTCTCTTCAACTTCTCTGCAAGAGGGCTTTTAAAAGGAATAAACCTAAAGAAGATTATGTGAAGTTGTGTAAAAGTTTCATACACTATGCTGCAGGCCTTCCTTTGACTCTTAAAGTGTTGGGTTCTTATCTTTGTGGGAAAAATGAACTTGAATGGAAAGTAGCTTTGGAGAAAATTAAAAAGTTCCCACCAGCGGATGTTCTGAAGAGACTTAGAGTAAGCTATGATGCATTAGGTGAAGTGGAAAAGAAAATTTTTTTGGATATTGCATGTTTTTTTAAAGGAATGGTCAAAGATCAAGTGACACAAATATTTGAAATAAGTGAACTTTATCCACAACTTGCAATAAGAGAACTTGTGGAGAAATGCTTGATAATTGAATACTATTCTGATCATGGGACTTGGTGTTTGGGTATGCATGATATCCTTCAAGAAATGGGTACAACTATTGTTTTGGAGGAATCACCTCATGATCCTAGCAGAAGAAGTAGATTATGGTCACTAAAAGATATTGATCGTGTGATGACAAAGAACAAAGGCTCAGACGTGCTGGAAGTGATACATCTTCAATCATCTACGCCATATGATTCAAATTGGGATCCTGAAGTATTCACTATGATATGCAATCTCAGAATACTTATCATAGCATGTGATTTACACCTTCCTCATGGCCTCAAATGTCTTCCTAGTTCACTAAAAATTCTTGAATGGAAATCATATCCTTTGAATTACCTTCCATCTGGTGGAAATCTAGATCAACTTGGTGTCCTTAAAATGCATCATAGCAAGATTGAACAACTTTGGAAGAGAACACATATTTTAGAAAAGTTGAAGCTCATTGATCTTAGTTATTCTGAAGAGTTTAGGACAACTCCTGATTTTTCGATGCTACCCAACCTGGAGCAACTGGTTCTTGAAGGTTGCATAAAACTTGTTGAGGTTCACCCATCACTTGCACAACATAAGAAACTACTTGTGCTGGACTTCAAAGATTGCAAGAATCTTAAAGCTCTTCCCACTAGAATGGAAATGGATTCATTGAATAAGTTGATCCTTTCAGGATGCTTGAAAATTAAGAAACTTCCAGAGTTTGGAAAAAATATGAGCAACCTATTGGTTCTTGATATGAAAAATTGCAAAAAGCTTGTTTGCCTTCCAAGTTCAATTTGTAACTTGAAATCTCTGAAAATTCTGAATATTTTAGGTTGCTCGAAATTTTCTTCATTGCCAGAAAACTTGAATGAAAATAACTGTCTAGAGGAGCTTGATTTGAGTGAAACTGCCATCAGAGAAATTCCTTCATCGACCATTGGCCTGCAAAATTTGAAGCTACTATATTTGAGAGGATGTAAAGGTTTGAGTTCAAGATCCAATTCATTAGTAAGGAGCTTGCTTTCCTCAGTTCAACAGGTATTTGGGCTTCATAATGAATCTCCCACAAGCTCCATGTATCTTTCTTTCATCTCAAGTATGGCATCGTTGAAGGAATTGAATTTAGAATACTGTAACCTGAAAGCTGGATCAATTCCAAATGAAATTCGTTGTTTAACAACATTGGAATATCTTAGTCTAGCTAGAAATGATTTTGGCAATGCATCCACAGGTAACTGGGCGCTTCCTCCTTCATTGAAGTGTTTAAAAATATCTAATTGTAATCTCAATGATGGTTCAATTCCTAATGACCTTAATAGCTTATCAGCATTGGAGACACTTAGTATAGGAGGAAACAATTTTACACATGTACCTGCTGGTTGTATCTCTAACCTCTTGCATCTTCGTAATCTTCATTTGAGTCACTGCCCATGGCTTAAGTTTCTGCCAGATCTCCCACCAAATTTACAACGTATTGATACCGTTGCTTGCCATTCATTGCAAACTTTGTCGTATCCAGAGTTGCTATTGAAGTGTATGGCTTTCTCAAATGTTTCCGTGGAATCTATTCCTCCTCATATGCACACAAATAACAACCGAGCTGGTATCTGGTGGACCCTAGGTGGTGAAATCCCATCATGGTTCCACAACCAAGATTTCAAAGTACTTGATAAAATTGAGAGTCGTGATGTTGTACAAGTTGATTCTGATTCCATTGTGTCAGTGGAAGTAGATGTCGCTGATTTTCGCGGTTCGAGTGGAAGTTGGGGAATTTCTCTTTGTGTTGTCGTACAAGATGTGAACCTTGATGATGATGTGTTCGATCTTTACCTTTGGATGACTCATAAAGCTTCAGAAGAAGAATTCGTTAAGAAAGACCTACGGTGGCGTGTTGTTTTTAGAGGGGATTCCCACCAAATCTTGACCATGTATTTGCCCTCCAGCAATTTTGCAGTTGATTGCATCAAGGTCGAATTCATATTTTATACAACAAAAACTATGTGTGGGGAAGCAGAATTGGATATGAAAGCCGACAGTGGAGATCATGGCAAGTTCATAATAAGCAAGTGTGGTTGGCGTGTGACACGCAAGGAAGATGTGGAAGAATGGCTCAGAACAATCCAAAAATGCAGCAGTACCAGTGACAACAATGAAATCCTTTCCGAAGAATCTGTGCACGGAAAGAGATACCGTGAAGGGGAAGAAGACCTGCAAGAAGAAGTCACTGTCAGTGAAACACATTCAGCTCGACAAAGTAAACTTAAAAGGTTTTCTTGA | 3696 | 0.3774 | MNMTIAPWKYHVFLSFRGEDTRKGFTDHLNATLKQRGIITFLDDKLNKGEVISDQLLLAIDESLISLVILSESYASSRWCLDELQRILESKKSLGREVIPIFYKVDPSDVRYQRGTFGCALQKHGDRFAENKDKVQRWKDALKEVANISGYDSRDRNEGKLIEEIVADVWSKLQPKLSYCFSNELVGIESKIEQVNSLLKIGLDDGRRRFLGIWGMGGIGKTTLAREIFERICGDFDMSCFLANVKEKSETKQGLVYLQRRLLSKLKIRDLEVDDTYEGRNLIRNLLCNKKLLLVLDNVSEISQLENLSIKQAWLGCGSRVIVTTRNLQVLIAHGEFEIYEAELLNDNESLQLLCKRAFKRNKPKEDYVKLCKSFIHYAAGLPLTLKVLGSYLCGKNELEWKVALEKIKKFPPADVLKRLRVSYDALGEVEKKIFLDIACFFKGMVKDQVTQIFEISELYPQLAIRELVEKCLIIEYYSDHGTWCLGMHDILQEMGTTIVLEESPHDPSRRSRLWSLKDIDRVMTKNKGSDVLEVIHLQSSTPYDSNWDPEVFTMICNLRILIIACDLHLPHGLKCLPSSLKILEWKSYPLNYLPSGGNLDQLGVLKMHHSKIEQLWKRTHILEKLKLIDLSYSEEFRTTPDFSMLPNLEQLVLEGCIKLVEVHPSLAQHKKLLVLDFKDCKNLKALPTRMEMDSLNKLILSGCLKIKKLPEFGKNMSNLLVLDMKNCKKLVCLPSSICNLKSLKILNILGCSKFSSLPENLNENNCLEELDLSETAIREIPSSTIGLQNLKLLYLRGCKGLSSRSNSLVRSLLSSVQQVFGLHNESPTSSMYLSFISSMASLKELNLEYCNLKAGSIPNEIRCLTTLEYLSLARNDFGNASTGNWALPPSLKCLKISNCNLNDGSIPNDLNSLSALETLSIGGNNFTHVPAGCISNLLHLRNLHLSHCPWLKFLPDLPPNLQRIDTVACHSLQTLSYPELLLKCMAFSNVSVESIPPHMHTNNNRAGIWWTLGGEIPSWFHNQDFKVLDKIESRDVVQVDSDSIVSVEVDVADFRGSSGSWGISLCVVVQDVNLDDDVFDLYLWMTHKASEEEFVKKDLRWRVVFRGDSHQILTMYLPSSNFAVDCIKVEFIFYTTKTMCGEAELDMKADSGDHGKFIISKCGWRVTRKEDVEEWLRTIQKCSSTSDNNEILSEESVHGKRYREGEEDLQEEVTVSETHSARQSKLKRFS | 1231 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Accr4g02609 | 1231 | Gene3D | - | 178 | 336 | IPR027417 | - | |
Accr4g02609 | 1231 | Gene3D | Ribonuclease Inhibitor | 532 | 692 | IPR032675 | - | |
Accr4g02609 | 1231 | SUPERFAMILY | P-loop containing nucleoside triphosphate hydrolases | 176 | 438 | IPR027417 | - | |
Accr4g02609 | 1231 | SMART | till_3 | 9 | 148 | IPR000157 | GO:0007165 | |
Accr4g02609 | 1231 | MobiDBLite | consensus disorder prediction | 1194 | 1231 | - | - | |
Accr4g02609 | 1231 | PRINTS | Disease resistance protein signature | 210 | 225 | - | - | |
Accr4g02609 | 1231 | PRINTS | Disease resistance protein signature | 286 | 300 | - | - | |
Accr4g02609 | 1231 | PRINTS | Disease resistance protein signature | 379 | 393 | - | - | |
Accr4g02609 | 1231 | PRINTS | Disease resistance protein signature | 715 | 731 | - | - | |
Accr4g02609 | 1231 | Pfam | NB-ARC domain | 191 | 418 | IPR002182 | GO:0043531 | |
Accr4g02609 | 1231 | SUPERFAMILY | RNI-like | 833 | 985 | - | - | |
Accr4g02609 | 1231 | SUPERFAMILY | Toll/Interleukin receptor TIR domain | 6 | 151 | IPR035897 | - | |
Accr4g02609 | 1231 | Gene3D | Ribonuclease Inhibitor | 693 | 822 | IPR032675 | - | |
Accr4g02609 | 1231 | Gene3D | - | 344 | 428 | IPR042197 | - | |
Accr4g02609 | 1231 | ProSiteProfiles | TIR domain profile. | 8 | 173 | IPR000157 | GO:0007165 | |
Accr4g02609 | 1231 | Gene3D | Ribonuclease Inhibitor | 823 | 1024 | IPR032675 | - | |
Accr4g02609 | 1231 | Gene3D | - | 6 | 177 | IPR035897 | - | |
Accr4g02609 | 1231 | Pfam | TIR domain | 9 | 187 | IPR000157 | GO:0007165 | |
Accr4g02609 | 1231 | MobiDBLite | consensus disorder prediction | 1194 | 1216 | - | - | |
Accr4g02609 | 1231 | FunFam | Disease resistance protein (TIR-NBS-LRR class) | 6 | 175 | - | - | |
Accr4g02609 | 1231 | PANTHER | LEUCINE-RICH REPEAT-CONTAINING PROTEIN | 10 | 712 | IPR044974 | GO:0006952 | |
Accr4g02609 | 1231 | SUPERFAMILY | L domain-like | 488 | 878 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Accr4g02609 | Accr-Chr4 | 52700249 | 52708719 | Dispersed/Transposed |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Accr4g02609 | 10 | 810 | WRKY Transcription Factor Family | AT4G12020 | 31.486 | 4.95e-96 | 337 |